Compared with other pharmaceutical companies in Chongqing, the treatment is much better, the welfare and income of employees are good, and there are more allowances. And very formal, and I won't work overtime on weekends. After all, it is a listed company.
From the perspective of the company's growth, it is a good pharmaceutical company with great potential and is supported by the Chongqing municipal government. Chongqing Winbond Pharmaceutical Co., Ltd. was formally established in September, 20001year. Is a joint-stock high-tech pharmaceutical enterprise with a registered capital of10.32 billion, nearly 600 employees and total assets of several hundred million yuan. In March 2000, Winbond Pharmaceutical was awarded the title of "National Key High-tech Enterprise" by the Ministry of Science and Technology. In April 2000, the first enterprise in Chongqing passed the national GMP certification; In 2003, he won the "National May 1 Labor Award"; It has been rated as "Top 50 Industrial Enterprises in Chongqing" and "Excellent Enterprises in Chongqing High-tech Development Zone" for many years. On June 25th, 2004, the company was listed on Shenzhen Stock Exchange.
Its core competitiveness is in the field of dermatology treatment and tuberculosis treatment, and it has a good corporate brand image. Is a professional manufacturer of domestic R&D, production and sales of retinoic acid drugs.